Nightingale Health: A promise in preventive health care with high risk
Inderes
Nightingale is a technology company built around blood analysis that tries to reduce lifestyle diseases through preventive health care. The preventive health care market has considerable global potential and Nightingale’s competitiveness seems promising. Even though the risks related to the functionality of the technology are clearly starting to subside, the commercialization of the technology is only in its initial stages. The investor carries a considerable risk related to the success of the commercialization, and thus the company’s risk profile is not suitable for those looking for a stable investment target.
Nightingale Health operates in the medical technology sector. The company specializes in the development of medical technology products. The product portfolio is broad and includes platforms and services within blood analysis that are used for disease prevention purposes. In addition to the main business, service and related ancillary services are also offered. The business is operated globally with the largest presence in Europe.
Read more on company pageForum discussions
